| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.15 | 8e-06 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-05 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.13 | 8e-05 |